Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

SAGA Metals Mobilizes and Commences Summer Work Programs...

June 27, 2025

SAGA Metals Announces Non-Brokered Private Placement

October 1, 2025

Joe Cavatoni: Gold’s Key Driver Now, Catalyst for...

July 24, 2025

Top 5 Canadian Mining Stocks This Week: Focus...

August 16, 2025

Skyharbour Consolidates 100% Interest in the Russell Lake...

November 17, 2025

Alice Queen: Exploring High-grade Epithermal Gold with Near-term...

August 22, 2025

IR1:IR1 Completes Acquisition to Consolidate Black Hills, US

September 10, 2025

Altech Batteries LtdSpherical Coated Silicon Achieves 88.5% Retention

October 9, 2025

FinEx Metals Provides Exploration Update on Ruoppa Gold...

July 22, 2025

Top 5 Small-cap Pharma Stocks of 2025

August 16, 2025